p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis

Experimental and Molecular Pathology

Volumn 83, Issue 3, 2007, Pages 367-376

  Murata, Kengo ^a,b   Ota, Satoshi ^a   Niki, Toshiro ^a,c   Goto, Akiteru ^a   Li, Chih Ping ^a   Ruriko, Urbiztondo Maria Rhea ^a   Ishikawa, Shumpei ^d   Aburatani, Hiroyuki ^d   Kuriyama, Takayuki ^b   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Dexamethasone; Idiopathic pulmonary fibrosis; jagged 1; Lung carcinoma; N Acetyl l cysteine; p63; Pirfenidone; Squamous metaplasia; Transforming growth factor

Indexed keywords

ACETYLCYSTEINE; CYTOKERATIN 14; CYTOKERATIN 6; DEXAMETHASONE; INVOLUCRIN; KERATIN; PIRFENIDONE; PROTEIN P63; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; DISEASE MODEL; DNA MICROARRAY; DOWN REGULATION; ENZYME INHIBITION; ENZYME REPRESSION; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; SQUAMOUS CELL METAPLASIA; WESTERN BLOTTING;

ACETYLCYSTEINE; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATIN-14; KERATIN-6; MEMBRANE PROTEINS; METAPLASIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; PROTEIN PRECURSORS; PULMONARY FIBROSIS; RESPIRATORY MUCOSA; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 36048960476     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.03.006     Document Type: Article

References (45)

1. ATS, and ERS. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 161 (2000) 646-664
2. Aubry M., Myers J., Douglas W., Trazelaar H., Washington T., Tanya L., Hartman T., Deschamps C., and Pankratz V. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin. Proc. 77 (2002) 763-770
3. Azuma A., Nukiwa T., Tsuboi E., Suga M., Abe S., Nakata K., Taguchi Y., Nagai S., Itoh H., Ohi M., et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 171 (2005) 1040-1047
4. Belinsky S.A., Nikula K.J., Palmisano W.A., Michels R., Saccomanno G., Gabrielson E., Baylin S.B., and Herman J.G. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11891-11896
5. Bouros D., Hatzakis K., Labrakis H., and Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 121 (2002) 1278-1289
6. Budunova I.V., Kowalczyk D., Perez P., Yao Y.J., Jorcano J.L., and Slaga T.J. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis. Oncogene 22 (2003) 3279-3287
7. Chilosi M., Poletti V., Murer B., Lestani M., Cancellieri A., Montagna L., Piccoli P., Cangi G., Semenzato G., and Doglioni C. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab. Invest. 82 (2002) 1335-1345
8. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., MacNee W., Thomeer M., Wallaert B., Laurent F., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 353 (2005) 2229-2242
9. Desmouliere A., Geinoz A., Gabbiani F., and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122 (1993) 103-111
10. Edwards D.R., Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J., Angel P., and Heath J.K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO. J. 6 (1987) 1899-1904
11. Fine A., and Goldstein R.H. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 262 (1987) 3897-3902
12. Fishbane S., Durham J.H., Marzo K., and Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J. Am. Soc. Nephrol. 15 (2004) 251-260
13. Guo L., Degenstein L., Dowling J., Yu Q.C., Wollmann R., Perman B., and Fuchs E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 81 (1995) 233-243
14. Hironaka M., and Fukayama M. Pulmonary fibrosis and lung carcinoma: a comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma. Pathol. Int. 49 (1999) 1060-1066
15. Hubbard R., Venn A., Lewis S., and Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am. J. Respir. Crit. Care Med. 161 (2000) 5-8
16. Kawasaki H., Nagai K., Yokose T., Yoshida J., Nishimura M., Takahashi K., Suzuki K., Kakinuma R., and Nishiwaki Y. Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. J. Surg. Oncol. 76 (2001) 53-57
17. Kawasaki H., Ogura T., Yokose T., Nagai K., Nishiwaki Y., and Esumi H. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Human Pathol. 32 (2001) 1043-1049
18. Kawasaki H., Nagai K., Yoshida J., Nishimura M., and Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J. Surg. Oncol. 81 (2002) 33-37
19. Ke Y., Reddel R.R., Gerwin B.I., Miyashita M., McMenamin M., Lechner J.F., and Harris C.C. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 38 (1988) 60-66
20. Keane M.P., Belperio J.A., and Strieter R.M. Cytokine biology and the pathogenesis of interstitial lung disease. In: Schwarz M.I., and King Jr. T.E. (Eds). Interstitial Lung Disease (2003), BD Decker Inc, Hamilton 245-275
21. Keith R.L., Miller Y.E., Gemmill R.M., Drabkin H.A., Dempsey E.C., Kennedy T.C., Prindiville S., and Franklin W.A. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin. Cancer Res. 6 (2000) 1616-1625
22. Laurikkala J., Mikkola M.L., James M., Tummers M., Mills A.A., and Thesleff I. p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development 133 (2006) 1553-1563
23. Lechner J.F., Haugen A., McClendon I.A., and Pettis E.W. Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium. In Vitro 18 (1982) 633-642
24. Lechner J.F., Haugen A., McClendon I.A., and Shamsuddin A.M. Induction of squamous differentiation of normal human bronchial epithelial cells by small amounts of serum. Differentiation 25 (1984) 229-237
25. Masui T., Wakefield L.M., Lechner J.F., LaVeck M.A., Sporn M.B., and Harris C.C. Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 2438-2442
26. Maul R.S., and Chang D.D. EPLIN, epithelial protein lost in neoplasm. Oncogene 18 (1999) 7838-7841
27. Maul R.S., Song Y., Amann K.J., Gerbin S.C., Pollard T.D., and Chang D.D. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments. J. Cell Biol. 160 (2003) 399-407
28. McGrath J.A., McMillan J.R., Shemanko C.S., Runswick S.K., Leigh I.M., Lane E.B., Garrod D.R., and Eady R.A. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat. Genet. 17 (1997) 240-244
29. Merritt A.J., Berika M.Y., Zhai W., Kirk S.E., Ji B., Hardman M.J., and Garrod D.R. Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation. Mol. Cell. Biol. 22 (2002) 5846-5858
30. Meyer E.C., and Liebow A.A. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer 18 (1965) 322-351
31. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398 (1999) 708-713
32. Nickoloff B.J., Qin J.Z., Chaturvedi V., Denning M.F., Bonish B., and Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ. 9 (2002) 842-855
33. Overall C.M., Wrana J.L., and Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. Biol. Chem. 264 (1989) 1860-1869
34. Panos R.J., Mortenson R.L., Niccoli S.A., and King Jr. T.E. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am. J. Med. 88 (1990) 396-404
35. Park J., Kim D.S., Shim T.S., Lim C.M., Koh Y., Lee S.D., Kim W.S., Kim W.D., Lee J.S., and Song K.S. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 17 (2001) 1216-1219
36. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.T., and Lee H.B. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol. 16 (2005) 667-675
37. Ruzzi L., Gagnoux-Palacios L., Pinola M., Belli S., Meneguzzi G., D'Alessio M., and Zambruno G. A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J. Clin. Invest. 99 (1997) 2826-2831
38. Selman M., and Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac. Soc. 3 (2006) 364-372
39. Snijders A.M., Schmidt B.L., Fridlyand J., Dekker N., Pinkel D., Jordan R.C., and Albertson D.G. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24 (2005) 4232-4242
40. Terrinoni A., Smith F.J., Didona B., Canzona F., Paradisi M., Huber M., Hohl D., David A., Verloes A., Leigh I.M., et al. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. J. Invest. Dermatol. 117 (2001) 1391-1396
41. Thannickal V.J., Toews G.B., White E.S., Lynch J.P., and Martinez III F.J. Mechanisms of pulmonary fibrosis. Annu. Rev. Med. 55 (2004) 395-417
42. Westfall M.D., and Pietenpol J.A. p63: molecular complexity in development and cancer. Carcinogenesis 25 (2004) 857-864
43. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., and Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8 (1999) 723-730
44. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., and McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398 (1999) 714-718
45. Zeng Q., Li S., Chepeha D.B., Giordano T.J., Li J., Zhang H., Polverini P.J., Nor J., Kitajewski J., and Wang C.Y. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cells 8 (2005) 13-23